INS and type 1 diabetes mellitus: Heise et al reported insulin glargine and insulin degludec to have a similar (nocturnal) hypoglycaemic risk profile after performing aerobic exercise of moderate intensity in people with type 1 diabetes, without insulin dose reductions [14].